IC2PerMed key activity consist in developing appropriate approaches for Chinese and EU cooperation over Personalised Medicine research and innovation under the umbrella set by ICPerMed initiative.

3 Working groups (WG), constituted of experts balanced between EU and Chinese stakeholders and genders, support IC2PerMed consortium on following activities :

Working Group 1

  • Developping awareness and empowerment
  • Shaping sustainable health care

Working Group 2

  • Big data and ICT solutions
  • Bringing innovation to market

Working Group 3

  • Translating basic clinical research and beyond
  • Research Funding
  • Set a consistent conceptual framework for PM-related developments, by analysing potentials and challenges for EU-China collaboration in the fields and the needs for policy, programmes and actions to improve such conditions for upcoming collaborations
  • Identify research and innovation collaboration opportunities and potential projects supporting the setup of a sustainable, equitable PM developments
  • Contribute to the barriers and opportunities reports, to develop common views on the priorities and EU-China collaboration will provide improved competitiveness, performance and reinforced rights to patients
  • Propose new schemes for developing and co-developing strategic initiatives and actions that will foster the uptake of ICPerMed Actions by Chinese funding agencies
  • Help in linking EU and Chinese networks for mobilising the relevant stakeholders upon given topics

These 3 WG are to cover 6 thematics aligned with ICPerMed priorities, as detailed below:

  • WG1: Developing awareness and empowerment & 5.Shaping sustainable health care
  • WG2: Big data and ICT Solutions & 4.Bringing innovation to market;
  • WG3: Translating basic to clinical research and Beyond & 6.Research Funding
Access Working group papers

For more information or joining expert groups activities, please contact us